Clinical and microbiological outcomes of maternal bacteremia: the role of intrapartum antibiotic use, insights from an 11-Year cohort study
Maternal bacteremia, predominantly caused by Enterobacteriaceae, poses a serious risk to both mothers and newborns. The study highlights the association between intrapartum ampicillin use and ampicillin-resistant Enterobacteriaceae bacteremia in both mothers and the neonates, emphasizing the need for optimized infection control measures and tailored antibiotic protocols in obstetric care. These findings support further research to improve management strategies and reduce adverse outcomes related to maternal bacteremia.
Authors
- Maya Frank Wolf (ORCID: https://orcid.org/0000-0002-2060-3234)
- Raneen Abu Shqara (ORCID: https://orcid.org/0000-0002-0131-3936)
- Lior Löwenstein
- Omer Saporta
- Daniel Glickman
Institutions
- Bar-Ilan University (IL)
- Western Galilee Hospital (IL)
Publication Details
- Journal
- The Journal of Maternal-Fetal & Neonatal Medicine
- Published
- 2025-02-16
- DOI
- https://doi.org/10.1080/14767058.2025.2466216
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00